CVE:RLV Relevium Technologies - RLV Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Relevium Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. C$0.02 0.00 (0.00%) (As of 01/7/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume130,500 shsAverage Volume140,861 shsMarket CapitalizationC$6.66 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsInsider TradesHeadlines About Relevium TechnologiesRelevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand name; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.Read More Receive RLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address RLV Stock News HeadlinesJanuary 5, 2022 | finance.yahoo.comRelevium Provides Bi-Weekly Update to Management Cease Trade OrderNovember 19, 2021 | finance.yahoo.comRelevium Provides Update to Management Cease Trade Order and Other MattersFebruary 5, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! November 1, 2021 | finance.yahoo.comRelevium Announces Delay in Filing Annual Financial StatementsOctober 26, 2021 | finance.yahoo.comRelevium Provides Corporate Update on the Transaction to Acquire BioganixOctober 1, 2021 | finance.yahoo.comRelevium Technologies Completes Shares-For-Debt TransactionsAugust 12, 2021 | au.finance.yahoo.comUPDATE 1-Robinhood to buy fintech firm Say Technologies for $140 mlnJuly 2, 2021 | nz.finance.yahoo.comIntelligent Mobility Summit 2020 - Research Survey Analysis and Results - ResearchAndMarkets.comFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.July 2, 2021 | nz.finance.yahoo.comRussian NFT fair shows off its bidsJune 30, 2021 | ca.finance.yahoo.comRelevium Announces Settlement of the Outstanding NotesJune 15, 2021 | ca.finance.yahoo.comRelevium Announces Shareholder Townhall and Conference CallJune 4, 2021 | markets.businessinsider.comIIROC Trading Halt - RLVMay 5, 2021 | markets.businessinsider.comRelevium Provides Update on the Exclusive Supply of Medical Examination GlovesMay 1, 2021 | in.finance.yahoo.comPEAK6 Completes Second Investment In Sales Enablement Technology Leader SportsdigitaApril 29, 2021 | baystreet.caBiocannabix LOI for Research in Pediatric SpaceApril 29, 2021 | markets.businessinsider.comBiocannabix Enters Into LOI With IAM Health GmbHMarch 13, 2021 | au.finance.yahoo.comClubhouse Event Tonight: Join Mission Matters Today on Clubhouse Powered by Mission Matters Podcast and KISS PR Brand StoryMarch 11, 2021 | sg.finance.yahoo.comRelevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid AprilDecember 11, 2020 | markets.businessinsider.comRelevium Technologies Inc. StockNovember 27, 2020 | markets.businessinsider.comNews for Relevium Technologies Inc.October 12, 2020 | in.finance.yahoo.comRELEVIUM TECHN. INC. (6BX.MU)October 10, 2020 | in.finance.yahoo.comRelevium Technologies Inc. (RLLVF)October 9, 2020 | au.finance.yahoo.comRelevium Technologies Inc. Regi (6BX.SG)October 8, 2020 | in.finance.yahoo.comRelevium Technologies Inc. (6BX.F)September 17, 2020 | finance.yahoo.comIIROC Trading Resumption - RLVAugust 1, 2020 | www.bloomberg.comRelevium Technologies and H-Source Holdings Partner for the Strategic Development and Global Supply of Personal ProtectiveSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolCVE:RLV CUSIPN/A CIKN/A Webwww.releviumcorp.com Phone+1-514-8248559FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio8,068.50 Current Ratio0.85 Quick Ratio0.02 Sales & Book Value Annual SalesC$1.00 million Price / Sales6.64 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.00 per share Price / Book-6.67Miscellaneous Outstanding Shares332,883,000Free FloatN/AMarket CapC$6.66 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Aurelio Useche C.M.A. (Age 55)M.B.A., Pres, CEO & Director Comp: $184.42kMr. Mark Anthony Billings C.F.A. (Age 53)CFA, M.B.A., MBA, Chief Financial Officer Comp: $64kMr. Edward Ierfino B. Comm. (Age 55)Mang. of Investor Relations Mr. Abis HussainSr. Marketing OfficerMr. David A. JohnsonCorp. Sec.Key CompetitorsVigil Health SolutionsCVE:VGLAvivagenCVE:VIVHarvest One CannabisCVE:HVTRevive TherapeuticsCVE:RVVManitex CapitalCVE:MNXView All Competitors RLV Stock - Frequently Asked Questions How have RLV shares performed in 2023? Relevium Technologies' stock was trading at C$0.02 on January 1st, 2023. Since then, RLV stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2023 here. What other stocks do shareholders of Relevium Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), SoFi Weekly Income ETF (TGIF), Acquired Sales (AQSP), Aphria (APHA), Aldeyra Therapeutics (ALDX). What is Relevium Technologies' stock symbol? Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV." How do I buy shares of Relevium Technologies? Shares of RLV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Relevium Technologies' stock price today? One share of RLV stock can currently be purchased for approximately C$0.02. How much money does Relevium Technologies make? Relevium Technologies (CVE:RLV) has a market capitalization of C$6.66 million and generates C$1.00 million in revenue each year. How can I contact Relevium Technologies? Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The official website for the company is www.releviumcorp.com. The company can be reached via phone at +1-514-8248559. This page (CVE:RLV) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.